Published in PLoS One on February 09, 2011
Where does HIV hide? A focus on the central nervous system. Curr Opin HIV AIDS (2013) 1.07
HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysis. PLoS One (2012) 0.87
HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol (2012) 0.86
Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders. J Neurovirol (2013) 0.86
The HAND Database: a gateway to understanding the role of HIV in HIV-associated neurocognitive disorders. BMC Med Genomics (2015) 0.85
Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ1-42 secretion in SH-SY5Y neural cells. J Neurovirol (2015) 0.85
Eradication of human immunodeficiency virus from brain reservoirs. J Neurovirol (2014) 0.84
The meningeal lymphatic system: a route for HIV brain migration? J Neurovirol (2015) 0.82
Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8+ lymphocyte-depleted rhesus macaques with neuroAIDS. J Gen Virol (2014) 0.81
HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy. Biosystems (2014) 0.80
Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J Neurovirol (2015) 0.79
HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Cell Death Dis (2017) 0.75
HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity. PLoS One (2015) 0.75
Identification of dual-tropic HIV-1 using evolved neural networks. Biosystems (2015) 0.75
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell (2006) 4.13
The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J (1998) 3.17
Structure--function relationships in HIV-1 Nef. EMBO Rep (2001) 2.87
Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A (1991) 2.81
HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic (2010) 2.47
Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci (2002) 2.39
Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol (2001) 1.80
Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol (1999) 1.76
Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol (2008) 1.74
Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology (2006) 1.71
Prediction of the stability of protein mutants based on structural environment-dependent amino acid substitution and propensity tables. Protein Eng (1997) 1.69
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64
Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS (1995) 1.59
HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. J Biol Chem (2006) 1.51
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology (2004) 1.49
Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol (2003) 1.45
Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology (2007) 1.43
Macrophage signaling in HIV-1 infection. Retrovirology (2010) 1.35
HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat Chem Biol (2009) 1.29
Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci (2008) 1.28
A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J Virol (2007) 1.25
Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med (2005) 1.24
Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck. Biochemistry (2004) 1.14
Suppression of HIV-1 Nef translation by Sam68 mutant-induced stress granules and nef mRNA sequestration. Mol Cell (2009) 1.10
Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol (1996) 1.08
Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS One (2009) 1.08
Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol (2010) 1.07
Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res (2000) 1.04
HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS (1991) 1.02
Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. J Mol Biol (2004) 1.01
Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J Neurovirol (2007) 1.01
Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol (2002) 1.00
Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia. Eur J Clin Invest (2002) 0.99
Chemokines and brain functions. Curr Drug Targets Inflamm Allergy (2005) 0.94
Reading between the lines: SH3 recognition of an intact protein. Structure (1996) 0.93
CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable. Virology (2006) 0.92
HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol (2009) 0.89
Extracellular HIV-1 Nef increases migration of monocytes. Exp Cell Res (2006) 0.88
Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Res Hum Retroviruses (2010) 0.88
Similarities of viral proteins to toxins that interact with monovalent cation channels. AIDS (1991) 0.86
Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus. J Neurovirol (2003) 0.86
High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementia. AIDS Res Hum Retroviruses (2007) 0.85
Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses. Gene (2005) 0.85
Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study. Transgenic Res (2009) 0.85
High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. Sci China C Life Sci (2009) 0.83
Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum. Traffic (2003) 0.81
HIV pathogenesis: Nef loses control. Cell (2006) 0.81
A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol (2010) 0.80
Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia. J Neurovirol (2009) 0.79
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood (2004) 7.09
Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics (2010) 6.14
An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol (2009) 3.11
Immune-driven recombination and loss of control after HIV superinfection. J Exp Med (2008) 2.34
A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol (2008) 1.96
Evolutionary fingerprinting of genes. Mol Biol Evol (2009) 1.64
Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol (2005) 1.49
Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol (2009) 1.34
Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2004) 1.27
Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2008) 1.20
HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol (2010) 1.12
Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS One (2009) 1.08
Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol (2010) 1.07
Compensatory mutations are repeatable and clustered within proteins. Proc Biol Sci (2009) 1.06
Use of cellular HIV DNA to predict virologic response to maraviroc: performance of population-based and deep sequencing. Clin Infect Dis (2013) 1.06
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2006) 1.05
Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PLoS One (2009) 0.97
Differential effects on innate versus adaptive immune responses by WF10. Cell Immunol (2004) 0.96
Prediction of R5, X4, and R5X4 HIV-1 coreceptor usage with evolved neural networks. IEEE/ACM Trans Comput Biol Bioinform (2008) 0.95
Injection of human primary effusion lymphoma cells or associated macrophages into severe combined immunodeficient mice causes murine lymphomas. Cancer Res (2002) 0.94
Systemic immune system alterations in early stages of Alzheimer's disease. J Neuroimmunol (2013) 0.94
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency. AIDS (2008) 0.92
The AIDS and Cancer Specimen Resource: role in HIV/AIDS scientific discovery. Infect Agent Cancer (2007) 0.92
The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma. J Leukoc Biol (2009) 0.90
Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Rep (2011) 0.89
Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2010) 0.89
HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol (2012) 0.86
Replication fitness of multiple nonnucleoside reverse transcriptase-resistant HIV-1 variants in the presence of etravirine measured by 454 deep sequencing. J Virol (2013) 0.86
Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels. J Acquir Immune Defic Syndr (2008) 0.86
Comparison of population and 454 "deep" sequence analysis for HIV type 1 tropism versus the original trofile assay in non-B subtypes. AIDS Res Hum Retroviruses (2013) 0.86
Selection in coastal Synechococcus (cyanobacteria) populations evaluated from environmental metagenomes. PLoS One (2011) 0.85
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. J Acquir Immune Defic Syndr (2002) 0.85
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.85
Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer. Ann Surg Oncol (2012) 0.84
Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testing. J Clin Microbiol (2012) 0.83
High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. Sci China C Life Sci (2009) 0.83
Does functional improvement following TKA correlate to increased sports activity? Iowa Orthop J (2009) 0.82
In vitro selection of clinically relevant bevirimat resistance mutations revealed by "deep" sequencing of serially passaged, quasispecies-containing recombinant HIV-1. J Clin Microbiol (2010) 0.81
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint. J Antimicrob Chemother (2013) 0.80
The AIDS and Cancer Specimen Resource. Methods Mol Biol (2011) 0.80
Posterior-stabilized versus posterior cruciate ligament-retaining total knee arthroplasty. Iowa Orthop J (2009) 0.79
HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis? Curr HIV Res (2010) 0.79
Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol (2014) 0.78
Evolution of viral genomes: interplay between selection, recombination, and other forces. Methods Mol Biol (2012) 0.78
An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data. J Virol (2014) 0.78
Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing. PLoS One (2012) 0.78
HIV-miR-H1 evolvability during HIV pathogenesis. Biosystems (2010) 0.77
Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology. J Acquir Immune Defic Syndr (2017) 0.75
[Analysis of genetic diversity and biological functional site of HIV-1 gp120 from a patient with AIDS dementia complex]. Bing Du Xue Bao (2009) 0.75
Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome. Asian Pac J Cancer Prev (2014) 0.75
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based pre-exposure prophylaxis for prevention of HIV-1 infection. AIDS (2017) 0.75